Condition
Accurate Medication
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Unknown3
Clinical Trials (3)
Showing 3 of 3 trials
NCT03161496Unknown
Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants
NCT03161002Unknown
Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Ticagrelor
NCT03261908Unknown
A Pharmacogenomics Study of Simvastatin-Induced Adverse Drug Reaction
Showing all 3 trials